> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-150/
- Published: 2017-10-01T12:00:00.000Z
- Updated: 2026-09-14T22:53:29.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139756

[**Advisory Panel to Review Bayer Drug**](https://www.fdaweb.com/advisory-panel-to-review-bayer-drug/)  
*Federal Register* notice: FDA announces an 11/16 Antimicrobial Drugs Advisory Committee meeting that will review a Bayer NDA for ciprofloxacin inhalation powder, indicated for reducing exacerbations in non-cystic fibrosis bronchiectasis adult patients. 09/29/2017

[**Guide on Advancing Emerging Technology In Drug Manufacturing**](https://www.fdaweb.com/guide-on-advancing-emerging-technology-in-drug-manufacturing/)  
*Federal Register* notice: FDA makes available a guidance entitled “Advancement of Emerging Technology Applications for Pharmaceutical Innovation and Modernization.” 09/29/2017

[**Guide on Oncology Reproductive Toxicity Testing**](https://www.fdaweb.com/guide-on-oncology-reproductive-toxicity-testing/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Oncology Pharmaceuticals: Reproductive Toxicity Testing and Labeling Recommendations.” 09/29/2017

[**Comments Sought on Opioid Policy Committee**](https://www.fdaweb.com/comments-sought-on-opioid-policy-committee/)  
*Federal Register* notice: FDA seeks comments or suggestions on issues relevant to the agency’s newly established Opioid Policy Steering Committee. 09/29/2017

[**FDA Seeks Non-voting Members for Device Advisory Panels**](https://www.fdaweb.com/fda-seeks-non-voting-members-for-device-advisory-panels/)  
*Federal Register* notice: FDA requests that any industry organizations interested in participating in the selection of nonvoting industry representatives to serve on certain panels of the Medical Devices Advisory Committee notify the agency in writing. 09/28/2017

[**Mammography Quality Advisory Committee Renewed for 2 Years**](https://www.fdaweb.com/mammography-quality-advisory-committee-renewed-for-2-years/)  
*Federal Register* notice: FDA announces the renewal of the National Mammography Quality Assurance Advisory Committee. 09/27/2017

[**Public Hearing on New Device Use with Approved Drugs**](https://www.fdaweb.com/public-hearing-on-new-device-use-with-approved-drugs/)  
*Federal Register* notice: FDA announces an 11/16 public hearing on a potential approach for device sponsors who seek to obtain marketing authorization for their products that are labeled for a new use with an approved, marketed drug when the drug sponsor does not wish to collaborate on the new use. 09/26/2017

[**Guidance on Product Classifications**](https://www.fdaweb.com/guidance-on-product-classifications/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Classification of Products as Drugs and Devices & Additional Product Classification Issues.” 09/26/2017